{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:36:14Z","timestamp":1789994174602,"version":"4.0.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"vor","delay-in-days":1131,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Medical Microbiology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.4103\/ijmm.ijmm_17_400","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T02:31:27Z","timestamp":1525228287000},"page":"87-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Echinocandins: Their Role in the Management of Candida Biofilms"],"prefix":"10.1016","volume":"36","author":[{"given":"Subramanian","family":"Swaminathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Kamat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nalini Adele","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4103\/ijmm.IJMM_17_400_bib1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.drup.2007.04.002","article-title":"Resistance to echinocandin-class antifungal drugs","volume":"10","author":"Perlin","year":"2007","journal-title":"Drug Resist Updat"},{"key":"10.4103\/ijmm.IJMM_17_400_bib2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00134-014-3603-2","article-title":"Incidence, characteristics and outcome of ICU-acquired candidemia in India","volume":"41","author":"Chakrabarti","year":"2015","journal-title":"Intensive Care Med"},{"key":"10.4103\/ijmm.IJMM_17_400_bib3","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.micinf.2016.01.002","article-title":"Candida albicans biofilms: Development, regulation, and molecular mechanisms","volume":"18","author":"Gulati","year":"2016","journal-title":"Microbes Infect"},{"key":"10.4103\/ijmm.IJMM_17_400_bib4","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1345\/aph.1M139","article-title":"A clinical review of echinocandins in pediatric patients","volume":"44","author":"VandenBussche","year":"2010","journal-title":"Ann Pharmacother"},{"key":"10.4103\/ijmm.IJMM_17_400_bib5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3389\/fmicb.2015.00205","article-title":"Adhesion, biofilm formation, cell surface hydrophobicity, and antifungal planktonic susceptibility: Relationship among Candida spp","volume":"6","author":"Silva-Dias","year":"2015","journal-title":"Front Microbiol"},{"issue":"Suppl 6","key":"10.4103\/ijmm.IJMM_17_400_bib6","doi-asserted-by":"crossref","first-page":"S618","DOI":"10.1093\/cid\/civ815","article-title":"The role of echinocandins in Candida biofilm-related vascular catheter infections: In vitro and in vivo model systems","volume":"61","author":"Ghannoum","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"10.4103\/ijmm.IJMM_17_400_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1469-0691.2000.00006.x","article-title":"Is there a need for new antifungal agents?","volume":"6","author":"de Pauw","year":"2000","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 6","key":"10.4103\/ijmm.IJMM_17_400_bib8","doi-asserted-by":"crossref","first-page":"S604","DOI":"10.1093\/cid\/civ814","article-title":"Echinocandins: The expanding antifungal armamentarium","volume":"61","author":"Aguilar-Zapata","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.4103\/ijmm.IJMM_17_400_bib9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/02681219780000961","article-title":"Lipopeptide inhibitors of fungal glucan synthase","volume":"35","author":"Kurtz","year":"1997","journal-title":"J Med Vet Mycol"},{"key":"10.4103\/ijmm.IJMM_17_400_bib10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1592\/phco.29.1.17","article-title":"Pharmacology and antifungal properties of anidulafungin, a new echinocandin","volume":"29","author":"Estes","year":"2009","journal-title":"Pharmacotherapy"},{"key":"10.4103\/ijmm.IJMM_17_400_bib11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1179\/joc.2011.23.6.319","article-title":"Echinocandins: Are they all the same?","volume":"23","author":"Mukherjee","year":"2011","journal-title":"J Chemother"},{"key":"10.4103\/ijmm.IJMM_17_400_bib12","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0140-6736(03)14472-8","article-title":"Echinocandin antifungal drugs","volume":"362","author":"Denning","year":"2003","journal-title":"Lancet"},{"key":"10.4103\/ijmm.IJMM_17_400_bib13","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1128\/AAC.01141-06","article-title":"Species-specific differences in the susceptibilities of biofilms formed by Candida bloodstream isolates to echinocandin antifungals","volume":"51","author":"Choi","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4103\/ijmm.IJMM_17_400_bib14","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ijantimicag.2009.07.001","article-title":"In vitro analysis of the occurrence of a paradoxical effect with different echinocandins and Candida albicans biofilms","volume":"34","author":"Miceli","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.4103\/ijmm.IJMM_17_400_bib15","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1128\/AAC.00095-07","article-title":"Paradoxical effect of echinocandins across Candida species in vitro: Evidence for echinocandin-specific and Candida species-related differences","volume":"51","author":"Chamilos","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4103\/ijmm.IJMM_17_400_bib16","unstructured":"Drug Approval Package: Cancidas (Caspofungin Acetate) NDA #21-227: U.S Food and Drug Administration; 2001. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2001\/21227_Cancidas.cfm. [Last accessed on 2017 Sep 15]"},{"key":"10.4103\/ijmm.IJMM_17_400_bib17","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1128\/AAC.01745-13","article-title":"In vitro study of sequential fluconazole and caspofungin treatment against Candida albicans biofilms","volume":"58","author":"Sarkar","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4103\/ijmm.IJMM_17_400_bib18","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1056\/NEJMoa040446","article-title":"Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia","volume":"351","author":"Walsh","year":"2004","journal-title":"N Engl J Med"},{"key":"10.4103\/ijmm.IJMM_17_400_bib19","first-page":"44","article-title":"The fungus among us: An antifungal review","volume":"35","author":"Kyle","year":"2010","journal-title":"US Pharm"},{"key":"10.4103\/ijmm.IJMM_17_400_bib20","unstructured":"Drug Approval Package: Mycamine (Micafungin Sodium) NDA #021506: U.S Food and Drug Administration; 2005. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2005\/21-506_Mycamine.cfm. [Last accessed on 2017 Sep 15]"},{"key":"10.4103\/ijmm.IJMM_17_400_bib21","first-page":"253","article-title":"Update on new antifungal therapy","volume":"18","author":"Juang","year":"2007","journal-title":"AACN Adv Crit Care"},{"key":"10.4103\/ijmm.IJMM_17_400_bib22","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/00365540410020406","article-title":"A multicenter, open-label clinical study of micafungin (FK463) in the treatment of deep-seated mycosis in Japan","volume":"36","author":"Kohno","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.4103\/ijmm.IJMM_17_400_bib23","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s10096-005-0024-8","article-title":"International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia","volume":"24","author":"Ostrosky-Zeichner","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.4103\/ijmm.IJMM_17_400_bib24","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1128\/AAC.03065-15","article-title":"Biofilm production and antibiofilm activity of echinocandins and liposomal amphotericin B in echinocandin-resistant yeast species","volume":"60","author":"Marcos-Zambrano","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 6","key":"10.4103\/ijmm.IJMM_17_400_bib25","doi-asserted-by":"crossref","first-page":"S652","DOI":"10.1093\/cid\/civ818","article-title":"Safety and efficacy of intermittent intravenous administration of high-dose micafungin","volume":"61","author":"Neofytos","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.4103\/ijmm.IJMM_17_400_bib26","unstructured":"Drug Approval Package: Eraxis (Anidulafungin) NDA #021632 & 021948: U.S Food and Drug Administration; 2006. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2006\/021632_021948_EraxisTOC.cfm [Last accessed on 2017 Sep 15]"},{"key":"10.4103\/ijmm.IJMM_17_400_bib27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1586\/14787210.5.1.45","article-title":"Anidulafungin: A new echinocandin for Candidal infections","volume":"5","author":"de la Torre","year":"2007","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.4103\/ijmm.IJMM_17_400_bib28","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/ja.2015.29","article-title":"Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: Data from the SENTRY antifungal surveillance program (2010-2012)","volume":"68","author":"Pfaller","year":"2015","journal-title":"J Antibiot (Tokyo)"},{"key":"10.4103\/ijmm.IJMM_17_400_bib29","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/ja.2013.83","article-title":"In vitro effectiveness of anidulafungin against Candida sp. Biofilms","volume":"66","author":"Rosato","year":"2013","journal-title":"J Antibiot (Tokyo)"},{"key":"10.4103\/ijmm.IJMM_17_400_bib30","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1128\/AAC.00057-14","article-title":"Activities of fluconazole, caspofungin, anidulafungin, and amphotericin B on planktonic and biofilm Candida species determined by microcalorimetry","volume":"58","author":"Maiolo","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4103\/ijmm.IJMM_17_400_bib31","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/1471-2334-13-219","article-title":"Intravenous anidulafungin followed optionally by oral voriconazole for the treatment of candidemia in Asian patients: Results from an open-label phase III trial","volume":"13","author":"Mootsikapun","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.4103\/ijmm.IJMM_17_400_bib32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/11585270-000000000-00000","article-title":"Echinocandin antifungal drugs in fungal infections: A comparison","volume":"71","author":"Chen","year":"2011","journal-title":"Drugs"},{"key":"10.4103\/ijmm.IJMM_17_400_bib33","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1111\/ajt.12963","article-title":"Randomized, double-blind trial of anidulafungin versus fluconazole for prophylaxis of invasive fungal infections in high-risk liver transplant recipients","volume":"14","author":"Winston","year":"2014","journal-title":"Am J Transplant"},{"key":"10.4103\/ijmm.IJMM_17_400_bib34","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/02713683.2016.1170857","article-title":"A comparative study of the effects of intravitreal anidulafungin, voriconazole, and amphotericin B in an experimental Candida endophthalmitis model","volume":"42","author":"Karagoz","year":"2017","journal-title":"Curr Eye Res"},{"key":"10.4103\/ijmm.IJMM_17_400_bib35","doi-asserted-by":"crossref","first-page":"818","DOI":"10.5301\/ijao.5000028","article-title":"Biofilm formation of Candida spp. isolates from patients at a cardiothoracic Intensive Care Unit","volume":"34","author":"Tobudic","year":"2011","journal-title":"Int J Artif Organs"},{"key":"10.4103\/ijmm.IJMM_17_400_bib36","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jinf.2015.12.008","article-title":"Antifungal activity against planktonic and biofilm Candida albicans in an experimental model of foreign-body infection","volume":"72","author":"Maiolo","year":"2016","journal-title":"J Infect"},{"key":"10.4103\/ijmm.IJMM_17_400_bib37","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1128\/AAC.46.11.3634-3636.2002","article-title":"In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies","volume":"46","author":"Ramage","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4103\/ijmm.IJMM_17_400_bib38","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1128\/AAC.01569-10","article-title":"In vitro activities of anidulafungin and other antifungal agents against biofilms formed by clinical isolates of different Candida and Aspergillus species","volume":"55","author":"Fiori","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4103\/ijmm.IJMM_17_400_bib39","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/AAC.00856-07","article-title":"Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms","volume":"52","author":"Katragkou","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4103\/ijmm.IJMM_17_400_bib40","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.4103\/ijmm.IJMM_17_400_bib41","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.cmi.2014.10.024","article-title":"ESCMID guideline for the diagnosis and treatment of biofilm infections 2014","volume":"21","author":"H\u00f8iby","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.4103\/ijmm.IJMM_17_400_bib42","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/annonc\/mdt545","article-title":"Central venous catheter-related infections in hematology and oncology: 2012 updated guidelines on diagnosis, management and prevention by the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology","volume":"25","author":"Hentrich","year":"2014","journal-title":"Ann Oncol"},{"key":"10.4103\/ijmm.IJMM_17_400_bib43","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.bmc.2016.01.026","article-title":"In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp","volume":"24","author":"Rosato","year":"2016","journal-title":"Bioorg Med Chem"}],"container-title":["Indian Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085720304424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085720304424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T19:17:25Z","timestamp":1759346245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0255085720304424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0255085720304424"],"URL":"https:\/\/doi.org\/10.4103\/ijmm.ijmm_17_400","relation":{},"ISSN":["0255-0857"],"issn-type":[{"value":"0255-0857","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Echinocandins: Their Role in the Management of Candida Biofilms","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4103\/ijmm.IJMM_17_400","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 Indian Journal of Medical Microbiology. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}